​
​

Karuna Therapeutics Ownership | Who Owns Karuna Therapeutics?

OverviewForecastFinancialsChartTranscripts

Karuna Therapeutics Ownership Summary

100.00% retail investors. Ifp advisors is the largest institutional shareholder, holding 0% of KRTX shares. Eventide Healthcare & Life Sciences I is the top mutual fund, with 0.50% of its assets in Karuna Therapeutics shares.

KRTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockKaruna Therapeutics--100.00%
SectorHealthcare Stocks 47.38%7.99%44.63%
IndustryBiotech Stocks 45.43%7.81%46.75%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ifp advisors---
Eversource wealth advisors---
Sachetta---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ifp advisors---
Eversource wealth advisors---
Sachetta---

Top Buyers

HolderShares% AssetsChange
Sachetta---1.00
Eversource wealth advisors---88.00
Ifp advisors---817.00

Top Sellers

HolderShares% AssetsChange
Ifp advisors---817.00
Eversource wealth advisors---88.00
Sachetta---1.00

Sold Out

HolderChange
Sachetta-1.00
Eversource wealth advisors-88.00
Ifp advisors-817.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20243-99.16%906-100.00%----100.00%1-98.89%
Dec 31, 202335931.02%37,214,897-1.67%1001.00%21965.91%902.27%
Sep 30, 2023274-11.90%37,848,8390.53%1001.00%132-21.43%88-4.35%
Jun 30, 202331118.70%37,647,946-2.63%1000.81%16812.75%9227.78%
Mar 31, 2023262-38,663,54411.66%1111.10%1492.76%72-4.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Eventide Healthcare & Life Sciences I190.00K0.50%-149.84K
Man GLG Event Driven Alternative IN USD158.28K0.41%133.26K
Fidelity Global Innovators Cl F131.60K0.34%-627.00
BlackRock Extended Mkt Composite83.56K0.22%12.03K
Arbitrage R79.08K0.21%79.08K
The Merger Fund A74.14K0.19%74.14K
UBS (Lux) EF Biotech (USD) P-acc69.72K0.18%-1.08K
T. Rowe Price US Smlr Cm Eq A USD61.85K0.16%5.12K
Allspring (Lux) WW At Rk Pr I USD Acc60.82K0.16%20.03K
TD US Mid-Cap Growth - I45.39K0.12%-

Recent Insider Transactions

DateNameRoleActivityValue
Mar 08, 2024Brannan Stephen K. Chief Medical OfficerSell$31.90K
Mar 08, 2024Brannan Stephen K. Chief Medical OfficerSell$1.56M
Feb 08, 2024Brannan Stephen K. Chief Medical OfficerSell$1.32M
Feb 08, 2024Brannan Stephen K. Chief Medical OfficerSell$258.95K
Jan 08, 2024Brannan Stephen K. Chief Medical OfficerSell$4.75M

Insider Transactions Trends

DateBuySell
2024 Q1-5
2023 Q4-12
2023 Q3-26
2023 Q2-10
2023 Q1-7

KRTX Ownership FAQ

Who Owns Karuna Therapeutics?

Karuna Therapeutics shareholders are primarily institutional investors at 0.00%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Karuna Therapeutics's industry, Biotech Stocks , is 45.43%, which Karuna Therapeutics falls below.

Does Blackrock own Karuna Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Karuna Therapeutics.

Who is Karuna Therapeutics’s biggest shareholder by percentage of total assets invested?

Ifp advisors is Karuna Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Karuna Therapeutics shares, valued at 0$.

Who is the top mutual fund holder of Karuna Therapeutics shares?

Eventide Healthcare & Life Sciences I is the top mutual fund holder of Karuna Therapeutics shares, with 0.50% of its total shares outstanding invested in 190K Karuna Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools